We compared gene expression profiles of mouse and human ES cells by immunocytochemistry, RT-PCR, and membrane-based focused cDNA array analysis. Several markers that in concert could distinguish undifferentiated ES cells from their differentiated progeny were identified. These included known markers such as SSEA antigens, OCT3/4, SOX-2, REX-1 and TERT, as well as additional markers such as UTF-1, TRF1, TRF2, connexin43, and connexin45, FGFR-4, ABCG-2, and Glut-1. A set of negative markers that confirm the absence of differentiation was also developed. These include genes characteristic of trophoectoderm, markers of germ layers, and of more specialized progenitor cells. While the expression of many of the markers was similar in mouse and human cells, significant differences were found in the expression of vimentin, h-III tubulin, alpha-fetoprotein, eomesodermin, HEB, ARNT, and FoxD3 as well as in the expression of the LIF receptor complex LIFR/IL6ST (gp130). Profound differences in cell cycle regulation, control of apoptosis, and cytokine expression were uncovered using focused microarrays. The profile of gene expression observed in H1 cells was similar to that of two other human ES cell lines tested (line I-6 and clonal line-H9.2) and to feeder-free subclones of H1, H7, and H9, indicating that the observed differences between human and mouse ES cells were species-specific rather than arising from differences in culture conditions. D 2004 Elsevier Inc. All rights reserved.
Introduction
Embryonic stem cell (ES cell) lines were first generated from mouse blastocysts by culturing inner cell mass (ICM) from pre-implantation embryos on feeder layers (Evans and Kaufman, 1981; Martin, 1981) . The resulting cultures contained populations of cells, which grew as colonies, showed extensive capacity for replication, and were pluripotent as demonstrated by their ability to generate chimeras and transgenic mice and to differentiate in culture into ectodermal, endodermal, and mesodermal derivatives.
Much has been learned from the generation of mouse ES cell lines in terms of methods of propagation, growth factor dependence, and marker expression. Mouse ES cells express genes characteristic of the early blastocyst such as the POU domain transcription factor OCT3/4 (Rosner et al., 1990; Scholer et al., 1990) , the homeobox domain transcription factor SOX-2 (Yuan et al., 1995) , the zinc finger protein REX-1 (Rogers et al., 1991) , the transcriptional activator UTF-1 (Okuda et al., 1998) , as well as carbohydrate epitopes SSEA-1, and SSEA-3 identified using specific antibodies at the preimplantation embryo stage (Krupnick et al., 1994) . Mouse ES cells do not differentiate into trophoectoderm (Edwards, 2002) , they can be propagated in continuous culture on a feeder layer of mouse embryonic fibroblasts or without feeders in the presence of leukemia inhibitory factor (LIF) (Smith and Hooper, 1987; Smith et al., 1988; Williams et al., 1988) or LIF-related cytokines (Conover et al., 1993; Pennica et al., 1995; Rose et al., 1994; Wolf et al., 1994) , retain high telomerase levels, show karyotypic stability, and retain the ability to contribute to chimeras and form teratomas (reviewed in Burdon et al., 2002; Edwards, 2002; Gardner, 2002; Prelle et al., 2002; Rossant, 2001 ) after multiple passages in culture.
More recently, primate and human ES cell lines have been isolated. The first success was reported by Thomson et al. who isolated several monkey (Thomson and Marshall, 1998; Thomson et al., 1998b) and subsequently five human ES cell lines (Thomson et al., 1998a) . This result has been replicated by several laboratories (reviewed in Carpenter et al., 2003) , and sixty-four different derivations are now listed in the NIH registry for research use (http:// escr.nih.gov). Currently, fewer than 10 cell lines are available in sufficient numbers for analysis, and only limited data on the fundamental properties of these lines are available. Recent studies, while limited, suggest that differences exist between mouse and human ES cell lines. Similar to mouse ES cells, which express mouse-specific embryonic antigens such as SSEA-1, at least some of the human ES cell lines express surface markers (glycolipids and glycoproteins) that were originally identified on human embryonic carcinoma cells (EC cells), such as SSEA-3, SSEA-4, TRA-1-81, TRA-1-60 Henderson et al., 2002) . On the other hand, human ES cells, unlike their mouse counterparts, do not appear to require LIF for their propagation or for maintenance of pluripotency (Reubinoff et al., 2000; Thomson et al., 1998a) . Whether LIF has different effects or its action is actively inhibited in human ES cells as has been proposed in EC cells (Schuringa et al., 2002) remains to be determined. Furthermore, in contrast to mouse ES cells (Niwa et al., 2000; Rossant, 2001 ), human ES cells are able to differentiate into trophoblast-like cells (Odorico et al., 2001; Thomson et al., 1998a) . Telomerase biology is different between mouse and humans (Forsyth et al., 2002) and differences in telomerase regulation in ES cells are likely, though no reliable comparisons exist. These differences suggest that caution must be exercised in extrapolation of the data that has accumulated on the properties of mouse ES cells to studies using human ES cells, and further studies analyzing the similarities and differences between mouse and human lines are required.
In this manuscript, we have compared a commonly used mouse ES cell line (D3) with the most easily available human ES cell line (H1) to assess similarities and differences when the cells are grown under similar conditions by the same laboratory. We show that several of the markers used to assess mouse ES cells can be used to examine human ES cells as well. Differences exist, however, in morphology, patterns of embryonic antigen immunostaining, expression of differentiation markers, as well as expression profiles of cytokines, cell cycle, and cell death-regulating genes. These differences were consistent across three different human ES cell lines tested and suggest that fundamental species-specific differences exist.
Methods

Cell culture
Human ES cell line H1 was obtained from WiCell Research Institute, Inc., (Madison, WI) and cultured according to their instructions. Briefly, cells were cultured on mouse embryonic fibroblast (MEF) feeders in ES cell medium consisting of DMEM/F12 (Invitrogen/GIBCO 11330-032) supplemented with 20% knockout serum replacement, 100 mM MEM nonessential amino acids, 0.55 mM beta-mercaptoethanol, 2 mM L-glutamine, antibiotics/antimycotics, and with 4 ng/ml human basic fibroblast growth factor (bFGF) (all from Invitrogen/GIBCO). MEF's derived from E12.5 mouse embryo were purchased from StemCell Technologies, Inc. (Vancouver, Canada) . MEF were expanded on 0.5% bovine gelatin-coated dishes in DMEM medium (Invitrogen/ GIBCO, cat# 11965-092) supplemented with 10% FBS (heat inactivated, Hyclone cat# 3007103), 2 mM glutamine and 100 mM MEM nonessential amino acids. Subconfluent MEF's cultures were treated with 10 Ag/ml Mitomycin C (Sigma, St. Louis, MO) for 3 h to arrest cell division, trypsinized, and plated at 2 Â 10 4 /cm 2 onto 0.5% bovine gelatincoated dishes overnight. Feeders were washed twice with PBS, and then incubated in ES cell medium for at least 1 h before plating ES cells. MEF's of passages 2 -3 were used as feeders. ES cells plated on top of MEF feeders were cultured at 37jC in the atmosphere of 5% CO 2 /5% O 2 within a humidified tissue culture incubator from Thermo Forma. H9.2 and I-6 cells were cultured at 21% O 2 . When confluent (8 -10 days after plating), ES cells were treated with 1 mg/ml collagenase, type IV (Invitrogen/GIBCO) for 5 -10 min and gently scrapped off with 5-ml pipette. Cells were spun at 500 rpm for 3 min and the pellet was replated at 1:2 -3 split or used for RNA purification.
Mouse ES cell line D3 was obtained from ATCC and were first expanded on fibroblast feeders treated with 10 Ag/ml Mitomycin C as described above. In some experiments, STO-1 feeder cells (also from ATCC) were used. Subconfluent D3 cultures were trypsinized and replated (1:3 split) onto 0.5% bovine gelatin-coated tissue culture plates in the presence of 1,400 U/ml of leukemia inhibitory factor (LIF) (Chemicon, ESG1106) in mouse ES cell medium consisting of knockout Dulbecco's minimal essential medium (DMEM) (Invitrogen/ GIBCO 10829-018) supplemented with 15% ES-qualified FBS (Invitrogen/Gibco 16141-061), 100 mM MEM nonessential amino acids, 0.55 mM beta-mercaptoethanol, 2 mM Lglutamine, and antibiotics (all from Invitrogen/GIBCO). When confluent (2 -3 days after plating), D3 cells were harvested by trypsinization and replated for immunostaining 
Gene detection by RT-PCR
Total RNA was isolated from cell pellets using RNAeasy Qiagen mini protocol. cDNA was synthesized using 100 ng to 1 Ag of total RNA in a 20-Al reaction. Superscript II (Invitrogen), a modified Maloney murine leukemia virus RT, and Oligo (dT) 12 -18 primers were used according to the manufacturer's instructions. Aliquots of cDNA, equivalent to 1/20 of the above reaction, were used in a 20-Al reaction volume. PCR amplification of different genes was performed using RedTaq DNA polymerase (Sigma). PCR reactions were run for 35 cycles (94 jC for 30 s, 55 jC for 30 s, and 72 jC for 1 min) and incubated at 72jC for 10 min at the end to ensure complete extension. The PCR products were subjected to electrophoresis in 1.5% agarose gel containing 0.5 Ag/ml ethidium bromide. One hundredbasepair DNA ladder (Invitrogen; catalog # 10380-012) was used to estimate size of the amplified bands. Table 1 lists the primers used for RT-PCR.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde for 20 min at room temperature. Fixed cells were blocked for 1 h at room temperature with PBS/0.1% BSA/10% normal goat serum/ 0.3% Triton X-100 and then incubated overnight with primary antibodies in PBS/0.1% BSA/10% normal goat serum at 4jC. The list of primary antibodies and their working dilutions are shown in Table 2 . After three washes in PBS/0.1% BSA, fluorescent secondary antibodies (Molecular Probes and Jackson ImmunoResearch) at 1:200 dilution in PBS were incubated with cells for 1 h at room temperature to detect expression. Double labeling experiments were performed by simultaneously incubating cells in appropriate combinations of primary antibodies, followed by incubation with noncross-reactive secondary antibodies. Staining with antibodies against the cell surface markers E-NCAM, A2B5 was carried out in cultures of living cells without blocking in culture medium for 1 h at 37jC.
Staining for alkaline phosphatase was performed with a kit (Sigma 85L1-1-KT) according to the manufacturer's protocol.
Electron microscopy
Undifferentiated H1 and D3 were grown on a MEF feeders. Once they formed sizable colonies, they were fixed with 5% glutaraldehyde for 3 h and processed for electron microscopy. They were postfixed in osmium tetroxide, embedded in plastic, semi-thin sectioned at 1 Am, and stained with toluidine blue. In addition, thin sections were prepared for electron microscopy according to standard protocols (Wood et al., 1990 ).
cDNA microarrays
The nonradioactive GEArrayk Q series cDNA expression array filters for human and mouse cell cycle, apoptosis and cytokine genes (Cat #: HS-001N, HS-002N, HS-003N and MM-001N, MM-002N, MM-003N, respectively, SuperArray Inc.) were used according to the manufacturer's protocol. Total RNA was isolated from cell pellets using RNAeasy Qiagen mini protocol and kit. The biotin dUTP labeled cDNA probes were specifically generated in the presence of a designed set of gene-specific primers using total RNA (4 mg per filter) and 200 U MMLV reverse transcriptase (Promega). The array filters were hybridized with biotin-labeled probes at 60jC for 17 h. After that, the filters were first washed twice with 2 Â SSC/1% SDS and then twice with 0.1 Â SSC/1% SDS at 60 jC for 15 min each. Chemiluminescent detection was performed by subsequent incubation of the filters with alkaline phosphataseconjugated streptavidin and CDP-Star substrate. Array membranes were exposed to X-ray film. Quantification of the gene expression was performed with ScionImage software. Mode OD of each gene/spot was calculated and normalized to expression of GAPDH. Human and mouse 
Telomerase activity
Telomerase was measured using the telomeric repeat amplification protocol (TRAP) assay as described (Kim et al., 1994; Weinrich et al., 1997) , Terminal restriction fragment (TRF) size was determined using Southern hybridization as described (Allsopp et al., 1992; Harley et al., 1990) .
EST-enumeration
EST frequency counts of genes expressed in human ES cells were performed as described (Brandenberger et al., submitted for publication). Briefly, cDNA libraries of human ES cell lines H1, H7, and H9 grown in feederfree conditions, embryoid bodies (EB), and two differentiated subpopulations were constructed and submitted for EST sequencing. The EST sequences were assembled into overlapping sequence assemblies and mapped to the UniGene database of nonredundant human transcripts. Expression levels were assessed by counting the number of ESTs for a particular gene that were derived from the undifferentiated human ES cells and comparing them to the number of ESTs derived from the differentiated subpopulations. Statistical significance was determined using the Fisher Exact Test (Siegel and Castellan, 1988 
Results
Assessment of human and mouse ES cell cultures based on morphology and on expression of commonly used markers
Undifferentiated mouse and human ES cell were cultured and assessed by electron microscopy, immunocytochemistry and RT-PCR. Many similarities and numerous differences between the undifferentiated human H1 and mouse D3 cells were noted. On electron microscopy examination (Fig. 1) . H1 cells formed a 2-to 4-cell layer over the feeder cells. In contrast, D3 cells ( Fig. 1) formed aggregates with 4-10 cell layer thickness over the feeder layer. Phase contrast photographs (see Fig. 2A panels a and b) demonstrated that human ES cells unlike mouse ES cells formed round colonies with well-defined edges, a pattern similar to find- ings by other labs. Both the H1 and D3 cells had a large nucleus-to-cytoplasm ratio with numerous ribosomes. Both ES cell colonies had a clearly polarized structure with the ES cells harboring numerous villae facing the feeding medium. There were tight junctions and gap junctions among cells in both ES cell lines, especially close to the surface (Figs. 1C, D , F, and G for mouse and human cells, respectively). These findings were consistent with our immunostaining for Connexin 43 (see Fig. 3 ). No highly organized intermediate filamentous structures, such as neurofilaments, that are suggestive of differentiation were seen. Small aggregates of microtubular bundles ran in the perimeter of the nuclei. One finding that clearly segregated D3 cells from H1 cells was the presence of many apoptotic cells, especially close to the edge of the colony, and autophagosomes in almost a quarter of all of the mouse ES cells. These electron dense lysosomal structures were rare in human ES cells.
The quality of D3 and H1 cells cultured in our laboratory was confirmed by evaluating the expression of several markers that are expressed by undifferentiated ES cells (Carpenter et al., 2001; Reubinoff et al., 2000; Thomson et al., 1998a) . Mouse D3 cells expressed SSEA-1 but did not express SSEA-4, while H1 cells exhibited reciprocal expression of these stage-specific embryonic antigens (Fig. 2) . Both cell lines expressed SSEA-3, although SSEA-3-positive cells were less abundant in mouse cultures (data not shown). In addition, H1 cells (but not D3 cells) expressed TRA-1-60 and TRA-1-81 antigens (data for D3 cells not shown).
RT-PCR was performed to assess expression of genes characteristic for ES cells such as OCT3/4 (Okamoto et al., 1990; Rosner et al., 1990) , SOX-2 (Avilion et al., 2003; Cai et al., 2002) , BEX/REX-1 (Ben-Shushan et al., 1998; Rosfjord and Rizzino, 1994) , and TERT (Armstrong et al., 2000; Niida et al., 1998) . Bands of the appropriate size were observed for all these genes using species-specific primers (Fig. 2) , confirming that the cells grown in our laboratory appeared similar to previously described undifferentiated ES cells. OCT3/4 and SOX-2 protein expression was confirmed with immunostaining. Most D3 and H1 cells were positive for SOX-2 and Oct 3/4 ( Fig. 2 and data not shown). Overall, these results demonstrate that D3 and H1 cells were not different significantly in morphology, antigen immunostaining, and pluripotency marker expression when compared to reports from other laboratories but differed from each other. 
Additional markers that serve to characterize mouse and human ES cell lines
To expand the list of markers expressed in undifferentiated cells, we tested expression of additional markers of pluripotency that are thought to be controlled by OCT3/4 and SOX-2 genes, such as UTF-1 (Nishimoto et al., 1999; Okuda et al., 1998) , FOXD3 (Hanna et al., 2002) and FGFR-4 (McDonald and Heath, 1994; Niswander and Martin, 1992; Wilder et al., 1997) and telomerase-associated factors TERF1 and TERF2 (Broccoli et al., 1997; Karlseder et al., 1999; van Steensel and de Lange, 1997) . RT-PCR amplification of transcripts of all these genes except FOXD3 demonstrate their presence in both D3 and H1 cells (Fig.  2B) . Expression of FOXD3 was detected only in mouse cells. Immunostaining confirmed FGFR-4 protein expression on the cell surface of both human and mouse cells (Fig.  3A (a) and (b) ). Expression of TERT, TERF1, and TERF2 genes in both mouse ES and human ES was consistent with high telomerase activity measured with TRAP assay. Telomerase activity in both ES cell lines was as high as in HeLa tumor cells (Fig. 3E) .
We also tested the expression other cell surface markers reported to be present on blastocysts or other stem cell populations, such as gap junction proteins connexins-43 (Duval et al., 2002) and 45 (Rozental et al., 2000) , glucose transporter GLUT1 (Leppens-Luisier et al., 2001; Morita et al., 1994; Pantaleon et al., 2001) , and ABC transporter BCRP-1/ABCG-1 Lu et al., 2002; Zhou et al., 2002 Zhou et al., , 2001 . All of these genes could be readily detected in both H1 and D3 cells (Fig. 3B) . All except GLUT-1 were absent in feeder cells (data not shown), making these markers useful in distinguishing ES cells from contaminating feeder populations. Connexin 43 expression was confirmed by immunostaining in both mouse and human cells (Fig. 3A(c) and (d) ). The antibody against BCRP1 recognized only the mouse epitope in our experiments (Fig. 3A(e) ). The results of the RT-PCR and immunostaining for stem cell-specific markers are summarized in Table 3A . Markers detected in both mouse and human ES cells (black boxes) or unique to human ES cells (gray boxes) are highlighted.
Markers of differentiated phenotypes
Human ES cells, like nonhuman primate ES cells (but unlike mouse ES cells) are able to differentiate into trophoblast in culture (Odorico et al., 2001; Thomson et al., 1998a) . To assess the expression of trophoblast-related genes in H1 and D3 cells, we used published RT-PCR primers for early trophoectoderm markers to analyze their expression. Genes tested included Bex1/Rex3 (Williams et al., 2002) , eomesodermin (Russ et al., 2000) , and four other transcription factors: Mash2/Hash2, HEB, Hand-2 and HIF1beta/ARNT, all described by Janatpour et al. (1999) . As shown in Fig. 3C , both mouse D3 and H1 cells expressed BEX1/REX3. In addition, D3, but not H1 cells, expressed Table 3 Gene expression in human H1 and mouse D3 ES cells was analyzed using RT-PCR and immunostaining. Representative aryl hydrocarbon receptor nuclear translocator (ARNT) (Abbott and Probst, 1995; Jain et al., 1998) . Among other trophoectoderm markers tested, eomesodermin was persistently expressed in all human ES cell samples and HEB transcripts appeared in some but not all samples (data not shown). Mash2 and its human homolog Hash2 were also present in some RNA preparations from both cell types (Fig.  2C) . The results summarized in Table 3B suggest Besides identification of a set of positive ES cell-specific markers, we also sought to develop a set of negative markers to assess the state of differentiation of current ES cell lines. Genes that have been previously reported as markers of early differentiation into germ layers or into tissue-specific precursors were chosen as sensitive indicators of differentiation. Results are summarized in Table 3C . Several markers that were thought to be characteristic of differentiation were expressed by undifferentiated cultures of human and in mouse ES cells. Thus, GATA4, a zinc finger transcription factor, thought to be important for early endoderm/heart differentiation was present in both mouse and human ES cell lines, although cardiac actinin was not expressed (Fig. 3D and Table 3C ). EST frequency analysis confirmed expression of GATA4 (and detected no actinin) in undifferentiated cells and in embryoid bodies [3:3] . Mouse D3 cells expressed GATA2, which was not detected in undifferentiated human ES cells using RT-PCR and EST counts [0:1]. Another marker of visceral endoderm, alphafetoprotein (AFP) was present in H1 cells (Fig. 3D and Table 3C ), although not detected by EST scan. Immunos- taining studies also confirmed the presence of differentiation markers in both D3 and H1 cells. For instance, significant number of human H1 cells expressed vimentin. Double staining for vimentin and for a human marker of undifferentiated state TRA-1-81 showed no co-localization, suggesting that vimentin-positive cells were a differentiated cell population (Fig. 3A(g) ). Previous studies of human cell ES lines H7 and H9 cultured on Matrigel (Carpenter et al., 2001 ) demonstrated expression of neuronal precursor marker beta-tubulin class III in these cultures and was confirmed using EST frequency analysis for undifferentiated cells and embryoid bodies [2:8] . When the presence of beta-tubulin class III was tested with immunostaining in our cultures, human H1 cells were mostly beta-tubulin class III-negative, except at the edge of the colony, where expression of SSEA-4 antigen has been lost (Fig. 3A(i) and (k) ). However, betatubulin class III was found in mouse D3 cell cultures, where its expression co-localized with the mouse marker of undifferentiated cells, SSEA-1 (Fig. 3A(h) and (j) ). On the other hand, no vimentin was found in mouse ES cells (Fig. 3A(f) ). Patterns of expression of beta-tubulin class III and vimentin in D3 and H1 cells were confirmed with RT-PCR (Fig. 3D) . Mouse ES cells were grown without feeders for RNA purification and did not express keratin 14 (Fig. 3D) , neither was it expressed in human cell ES lines H1, H7, and H9 cultured on Matrigel without feeders (see Fig. 8B ).
In summary, broader analysis of stem cell markers identified additional partially overlapping marker sets markers, which could be used to assess the state of human and mouse ES cell cultures.
Comparison of cell proliferation and cell death gene expression in D3 and H1 ES cell lines
Given the differences observed by immunocytochemistry and by RT-PCR in marker and gene expression, it was reasoned that human and mouse cells will display additional differences in their cell cycle regulation and cytokine response. To directly test this, we employed focused microarrays containing 96 genes related to cell cycle or apoptosis as previously described (Luo et al., 2002) . To avoid a bias in hybridization, arrays containing human genes were used to probe expression in human cells, and homologous arrays of mouse genes (80 out of 96 genes were homologous) were used to assess expression in mouse cells. Relative OD of each spot on the array was quantified with ScionImage and normalized to GAPDH. All numbers below are percentages of GAPDH expression. The results of the cell cycle microarray are summarized in Fig. 4 . As can be seen in Figs. 4A and B, almost half of all genes on each array was expressed, providing evidence for cell proliferation in both types of ES cell cultures. Eleven of the mismatched genes were present at low or undetectable levels. Three genes which were absent on the mouse array and present on the human array were expressed at detectable levels: CDC28 protein kinase 2 (UniGene: Hs.83758; 6.4%; EST counts [3:0]; MAD2 (UniGene; Hs.19400; 3.97%; EST counts [6:3]); and CDC28 protein kinase 2 (UniGene Hs.83758; 6.42%). Mouse cells expressed two genes that were absent on the human array: E2F-related transcription factor (UniGene Mm.925; 6.13%) and p53-activated gene 14-3-3e or tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon (UniGene Mm.42972; 80.87%). Similarities and differences in expression of some key cell cycle regulators are summarized and compared to EST frequency scan for the same genes (see Table 4 ). Good correlation between two methods was observed though a few genes, which were not detected by EST scan (ND), were expressed at low levels as assessed by array analysis. In addition, the expression of two genes not present on the array and elevated in mouse ES cells were confirmed as being expressed E2F [2:2] and tyrosine 3-monooxygenase [20:21] .
As one would expect, markers of proliferation Ki67, PCNA, and cyclins were expressed, although with different patterns in each cell type. Expression of tumor suppressor genes such as ATM, Rb and retinoblastoma-like proteins, and of BRCA1 was not detected. Expression of p53 was low in human cells, but was higher in mouse cells (4.2% vs. 7.5%, respectively). Negative regulators of the p53 and Rb pathway such as mdm2 were present as well. Cell cycle inhibitors p21, p27, p18, and p19 were undetectable by hybridization, while p16 inhibitor was predominantly expressed in H1 cells (60.9% vs. 3.73%). Moderate expression of p15 inhibitor (8.3%) was observed in mouse cells only. Mouse cells also showed moderate expression (5.8%) of one of the DNA-binding replication proteins, RPA3 (Unigene: Mm.29073), which was absent in human cells.
The ubiquitination pathway appeared more active in H1 cells as ubiquitin C was virtually undetectable in mouse D3 cells but was present at high levels (65.5%) in human cells. GADD45 was readily detectable in the mouse D3 line (20.1%) but was low or absent in human cells (1.5%). MCM genes 2 through 7, which are thought to be ''DNA licensing factors'', which bind to the DNA after mitosis and enable DNA replication before being removed during S phase (Lei and Tye, 2001; Nishitani and Lygerou, 2002) . Expression of selected genes (ubiquitin C, p16ink, cyclin D2, mdm2, and GADD45) was confirmed with RT-PCR. Similar to the microarray results, ubiquitin C and CDK4 inhibitor p16ink were expressed at higher levels in I. Ginis et al. / Developmental Biology 269 (2004) 360-380 human ES cells, while other genes were expressed at similar levels (Fig. 4B) .
Examining regulation of cell death pathways showed the presence of a limited subset of genes (Fig. 5) . Nine and 17 genes were expressed at detectable levels in D3 and H1 cells, respectively (see Fig. 5A for the lists of these genes). Surprisingly, only 2 out of these 24 genes were expressed in both cell types. One was the anti-apoptotic BCL2-related gene MCL-1 (27.3% and 30.6% of for D3 and H1 cells, respectively); and the other was BAX (6.2% and 7.9% for D3 and H1, respectively), which causes cytochrome c release from mitochondria. Mouse, but not human cells, expressed additional BAX-related gene BIK (7.4% and 0% for D3 and H1, respectively). Human cells in contrast, expressed BAK (63.7%) and HRK (63.29%), other BAXrelated genes.
Many of the genes that were present at detectable levels in undifferentiated mouse ES cell cultures were associated with the p53 pathway (Fig. 4B) . Indeed, the p53 effecter GADD45 was highly expressed only in mouse ES cells (29.5%), and expression of another p53-dependent gene 14-3-3e (Mm.42972) was also high in D3 cells, although this gene had no counterpart in human apoptosis array. Human ES cells in contrast expressed higher levels of negative regulators of p53 function. These included mdm2 ubiquitin ligase, which binds p53 and destines it for ubiquitination and degradation (8.5% and 16.4% for D3 and H1 cells, respectively) .
In contrast to mouse ES cells, human ES cells expressed several genes associated with TNF receptor signaling. This includes high levels of p75 TNFR-2 (84.5% and 0% for H1 and D3 cells, respectively) and TNF receptor-docking molecule TNF receptor-associated factor TRAF1 (60.0% and 0.3% for H1 and D3 cells, respectively). These results have been confirmed with RT-PCR (Fig. 5B) , TRAF6, and TRAF4, as well as one of the members of the receptor-interacting family of Ser/Thr kinases RIP2 (5.3%) were also expressed predominantly in human ES cells, although to the lesser extent (RIP2 homologue was absent on the mouse array). Human ES cells demonstrated differentially high expression of a BLK gene (Hs.2243 and Mm.3962; 79.3% and 0%, respective- ly), a Src family protein tyrosine kinase, which participates in NF-kappa-B activation during B cell development. Many of the genes known to play an important role in cell death such as caspase 4/5, 8/9, FAS and FAS ligand were not expressed at detectable levels in either cell type. Human ES cells expressed, however, caspase 14, which was absent in mouse cells, while death receptor genes DR3 (UniGene: Hs.180338 and Mm.101198; 0% and 6.2%) and DR6 (which was only present on a mouse array, UniGene Mm.22649; 28.9%) were significantly expressed.
Overall these results show that both mouse and human cells are actively dividing cells, with mouse cells less protected from apoptosis consistent with the observation that many apoptotic cells are found in mouse ES colonies (see Fig. 1A ). The pathways used to regulate cell cycle and apoptosis differ significantly with a limited overlap of genes.
Cytokine expression by ES cells
Given the difference between mouse and human marker expression and the differences in expression of cell cycle and cell death pathways genes, we felt that differences in cytokines may also be apparent. While cytokines can vary greatly and message levels tend to be low, the overall pattern of expression can nevertheless provide a basis for comparison. The cytokine microarray contained probes for major cytokine subsets: bone morphogenetic proteins (BMPs), colony-stimulating factors (CSFs), fibroblast growth factors (FGFs), interferons (INFs), insulin-like growth factors (IGFs), interleukines (ILs), platelet-derived growth factors (PDGFs), transforming growth factors (TGFs), tumor necrosis factors (TNFs), vascular endothelial growth factors (VEGFs), many of which are known to be active during development. As can be seen in Fig. 6 , the overall patterns of cytokine expression in human and mouse ES cells were different (Fig. 6A) . Expression of many of the genes shown to be elevated by microarray analysis was confirmed by EST scan (Brandenberger et al., submitted for publication) or MPSS (our unpublished results) and a smaller number were confirmed by RT-PCR (Fig. 6C) . Few genes, IL-15, (Hs.168132), IL-11 (Hs.1721); pleiotrophin (Hs.44), VEGF (Hs.73793), BMP2 (Hs.73853), and TNFSF14 (LIGHT) (Hs.129708) were moderately expressed in both types of cells (Fig. 6B) . The repertoire of cytokines expressed in mouse D3 cells was richer than in human cells (Fig. 6B) .
LIFR/gp130 signaling pathways
We and others have noted that LIF is not required to maintain self-renewal of human ES cells, while it is critical for the maintenance of mouse cells. To identify the basis for the absence of the LIF requirement, we examined expression of both subunits of the LIF receptor: specific LIF receptor (LIFR) subunit and signal transducer gp130. As can be seen in Fig. 7C , LIFR message was absent in H1 cells, while LIFR could be readily detected in mouse Table 2 for antibody specifications. (Figs. 7A and B) . H9 cells and pooled RNA preparations from H1, H7, and H9 cells had low levels of LIFR mRNA (EST analysis of these cells confirmed low expression of LIFR [1:1]), while the newly developed human ES cell line I-6 expressed significant levels of LIFR (see Fig. 8B ). The failure to detect expression of LIFR in H1 cells could not be attributed to technical issues as it was verified with two different sets of LIFR primers (data not shown). Both sets of primers identified LIFR in human neuroepithelial cells and in human placenta (Fig. 7D) . Absence of LIFR message in H1 cells was consistent with immunostaining results: no LIF receptor was detected on the surface of H1 cells (Fig.  7G) , although the same antibody detected LIFR on mouse cells (Fig. 7E) . Expression of gp130, a signal-transducing subunit of LIFR, was high in mouse cells and was readily detected by RT-PCR (Fig. 7A) and immunostaining (Fig.   7F ). However, gp130 expression varied among human ES lines. H1 cells expressed low levels of gp130 gene (Fig.  7C) , while no message for gp130 was found in H9 cells and in cells grown without feeders on Matrigel (H1, H7 and H9 RNA pool) (see Fig. 8B ). The latter result is in accordance with zero EST counts for gp130 [0:6] in these cells. Since feeder cells also expressed gp130, it might be that the message for gp130 detected in RNA preparations from H1 cells can be attributed to contamination with feeder RNA. Indeed, immunofluorescence experiments showed quite low gp130 protein on the surface of H1 cells (Fig. 7H) . The variable expression of gp130 and LIFR suggested that this pathway is not active at early stages of huES cell self-renewal and is consistent with our observations that several inhibitors of this pathway are actively transcribed (Brandenberger et al., Geron personal communication see also Table 5 ). I. Ginis et al. / Developmental Biology 269 (2004) 360-380 374 Differences between mouse and human ES cells are conserved in independently isolated ES cell lines The significant differences observed between mouse and human ES cells in expression of pluripotency/differentiation markers, LIFR/gp130, apoptosis and cell cycle-related genes, and cytokines raised the possibility that differences were due to intrinsic differences in human and mouse cultures. Alternatively, these differences could arise from small differences in how cell lines were derived and maintained. To directly address this, we obtained RNA from two additional human ES cell lines: H9.2 clone of H9 and a newly derived line I-6 (Amit and Itskovitz-Eldor, 2002 ) that have been derived and propagated in a different lab. In addition, we tested pooled RNA sample from three different cell lines (H1, H9, and H7) that were propagated on Matrigel without feeders for 50 passages. Fig. 8A presents a list of markers that have been found differentially expressed in H1 and D3 cells (see Figs. 3B, C and D and Table 3 ). FOXD3, ARNT, beta-tubulin class III and GATA2 were not expressed in H1 cells and were present in D3 cells. As shown in Fig.  8B , all these genes were also absent in all human cell lines tested, while eomesodermin, HEB, AFP, and POTE (genes that were expressed in H1 but not in D3 cells) were present in other human cell lines as well. Keratin-14 message was absent in the pooled RNA from feeder-free human ES cells, and was present in feeder cell RNA, which confirms its origin from mouse fibroblasts.
ES cell cultures
Since microarray analysis provided the broadest overview of the cell's gene expression (see summary in Fig.  8C ), we sought to investigate whether gene expression profile of H1 cells will be reproducible in other human ES cell lines. We performed cell cycle microarray analysis with H9 cells, with the human ES line BG02 from Bresagen and with pooled human ES cell RNA and with two additional lines (Fig. 8 and data not shown) . A remarkable similarity in the pattern of expression of cell cycle genes among different populations of human ES cells was observed and this pattern was clearly distinct from that seen in mouse ES cells (Fig. 8D) . Thus, it appears likely that the differences we observe between mouse and human ES cells reflect underlying fundamental differences in cell biology of the two populations.
Discussion
We have compared the expression of almost 400 genes in human and mouse ES cells that have been maintained in an undifferentiated state on MEF's under standard protocols. Our results show that mouse and human cells share similarities in expressing markers of the pluripotent state. The expression of these markers together with the absence of markers of differentiation constitutes a signature profile of undifferentiated ES cell cultures (Figs. 1 -3 , Table 3 ) and is similar to recent results reported by microarray comparison (Sato et al., 2003) . The immunostaining markers and validated primers reported in this study will form the basis for developing a well-tested set of markers, which will allow careful, regular monitoring of ES cells in culture. It is important to note that the primers used in this study have been verified to amplify specific cDNA fragments in control Note the absence or low levels of expression of receptor and transducer components and the relatively high levels of inhibitors of the pathway such as phosphatase, PIAS and SOCS genes. nd = not detected, 0 = absent in ES cells but present after differentiation, tpm = transcripts per million, MPSS = massively parallel signature sequencing.
mouse and human fetal tissues using identical RT-PCR protocols. Band sizes were selected such that multiplex RT-PCR could be readily performed or amplified DNA fragments could be used to develop focused ES cell microarrays. However, signature profiles described in mouse and human ES cells were not identical. Apart from previously reported differences in expression of embryonic antigens (Henderson et al., 2002) and the ability to differentiate into trophoectoderm (Odorico et al., 2001; Thomson et al., 1998a) , other differences between human and mouse ES cells have been identified in these studies. These differences were conserved in all human ES lines tested ( Fig. 8 and Table 6 ). An important difference that we have noted is LIF receptor expression. LIFR message was low or absent in H1 and variable in all human ES lines tested, while LIFR could be readily detected in mouse ES cell cultures. Our failure to detect LIFR and gp130 was confirmed by an EST scan where we likewise detected inconstant/low levels of LIF receptor (Brandenberger et al., submitted for publication; Carpenter et al., 2004; Rosler et al., 2004) . These results are consistent with the lack of a LIF requirement for maintenance of undifferentiated human ES cell lines and with the altered LIF signaling observed in human teratocarcinoma lines (Schuringa et al., 2002) and the high levels of suppressors of the cytokine signaling pathway (Brandenberger et al., submitted for publication). Interestingly, EST enumeration detected significant levels of LIF embryoid bodies [2:9] suggesting that LIF may play a role in differentiation of these cells. Elucidation of the role of LIF in paracrine regulation of ES cells requires further investigation.
The presence of a LIF-independent self-renewal pathway has been described in mice (Dani et al., 1998) though it is thought to play a minor role in self-renewal (reviewed in Burdon et al., 2002; Niwa, 2001) . It is possible, however, that this pathway plays a larger role in human ES cell cultures. More recently, a homeobox protein, nanog, was shown to be involved in self-renewal via activation of a LIF independent pathway (Chambers et al., 2003; Mitsui et al., 2003) . Nanog expression is conserved in all human lines examined so far (Brandenberger et al., submitted for publication).
Another surprising difference between human and mouse ES cells, which we have noted, is absence of FoxD3 expression. The results of EST scan for FoxD3 [0:0] were consistent with our RT-PCR results although it should be noted that some reports (reviewed in Carpenter et al., 2003) have suggested expression of FoxD3 in human ES cells. In contrast to human cells, FoxD3 was readily detected in mouse ES cell cultures. FoxD3 or GENESIS is expressed early in mouse embryonic development, and abrogation of FoxD3 function leads to a failure of the blastocyst to develop beyond the four-cell stage (Hanna et al., 2002) . In addition, FoxD3 is critical for endodermal differentiation when it antagonizes the activity of OCT3/4 (Guo et al., 2002) . Differences in FoxD3 expression between mouse and human ES cells, if verified, would further illustrate fundamental differences in the biology of these cells.
Our studies of patterns of expression of cell cycle, apoptosis, and cytokine genes uncovered additional fundamental species-specific differences. While it is impossible to discuss all findings, it is worth highlighting a few critical differences that are not only of quantitative nature, but suggest that different signaling pathways are operative and thus may provide some insights on ES cell biology. For instance, components of a p53 pathway that controls growth arrest and cell death in response to DNA damage (Gottifredi et al., 2000; Schultz et al., 2000) were much more active in mouse ES cells, while human ES cells expressed TNF receptor 2, which has been implicated in a survival signaling cascade (Peschon et al., 1998) probably through NF-kB activation (Dopp et al., 2002) . Even when similar pathways were utilized, different members of the same family were more or less abundant. MCM6, for example, was high in human cells and MCM-2, MCM-3, and MCM-7 were high in mouse cells. Overall, the differences observed in array analysis between human and mouse ES cells were unexpectedly large, which suggests that caution needs to be exercised in extrapolating from studies in mouse cells.
Our analysis identified other unexpected findings. Human ES cells expressed additional markers of trophoectoderm, eomesodermin (Russ et al., 2000) , and HEB (Janatpour et al., 1999) , which was consistent with observations that human ES cell lines could differentiate into trophoectoderm (Odorico et al., 2001; Thomson et al., 1998a ). An additional surprising observation was the presence of a contaminating population of vimentin-immunoreactive cells interspersed within undifferentiated ES cells. Message for vimentin was present in RNA preparations as well. Vimentin-positive cells appear intercalated among the other cells in the colonies and cannot be readily distinguished by morphology. However, double immunostaining with the marker of undifferentiated cells TRA-1-81 showed no co-localization, suggesting that these cells are differentiated cells. Mouse cells did not express vimentin but expressed beta-tubulin class III, which co-localized with SSEA-1. Recently, ES cells were found to express betatubulin class V (unpublished results), which might crossreact with our reagents. Two alternative possibilities could explain numerous differences observed between mouse and human ES cells. One possibility is that culture conditions for growing human ES cells were not optimized for maintaining the cells in an undifferentiated state, and that the differences that we observed will be resolved as culture conditions improve. The observed differences may reflect some degree of differentiation, atypical expression of certain markers or transdifferentiation. We note, for example, the small number of differentiated cells of unknown character that were present in human ES cell cultures, and the expression of several markers of differentiated cells such as vimentin, keratin14, and beta III tubulin. However, our initial examination of additional human ES cell lines suggests that culture conditions alone could not explain the observed differences between mouse and human ES cells. Besides the H1 line, we have studied H9 cells and the newly developed line I-6, as well as ES cells grown without feeders for 50 passages and cell lines from Bresagan. The gene expression patterns in all these lines appeared similar to each other and differed from mouse ES cells. Since these lines were grown in different laboratories under distinct culture conditions, we would argue that observed dramatic differences between human and mouse cells reflect underlying differences in the biology of the cells rather than differences secondary to a response to the culture environment. However, we suggest that a careful assessment of a larger number of lines with additional markers will be required to make a final determination.
An alternate, equally plausible, explanation for the differences between mouse and human cells is that human ES cells may have been isolated at a slightly different perhaps earlier stage of blastocyst cell maturation, and thus the observed differences reflect the stage of harvesting of ICM. This possibility is consistent with the reported ability of human ES cells (and the inability of mouse ES cells) to differentiate into trophoblast or to contribute to placental development in vivo, and with our current observations of the expression of several early trophoectoderm markers and the expression of some of the putative differentiation markers such as AFP and GATA4 that would be consistent with the possibility that early harvested ES cells may retain the capability to make extra-embryonic endoderm and mesoderm.
In summary, our results show that the overall strategies to regulate self-renewal and differentiation are likely similar among ES cell lines from different species. However, significant differences are present and it will be important to identify and characterize such differences before a useful set of markers for the differentiated and undifferentiated state can be developed. Once such a marker set is developed and validated, it is likely that it can be used across all the 60 or so lines that have been identified. Our future experiments will be directed at extending the analysis to other lines as they become available and understanding the functional significance of the molecular differences we have observed.
